Trilaciclib Impurity 2;1374743-01-7
=
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Product Number: T092004
English Name: Trilaciclib Impurity 4
English Alias: 2'-(methylsulfonyl)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one
CAS Number: 2170747-01-8
Molecular Formula: C15H18N4O3S
Molecular Weight: 334.39
Product Advantages: Trilaciclib Impurity 4 has extremely high purity and good chemical stability. Its structure has been strictly confirmed by precise analytical methods such as nuclear magnetic resonance and mass spectrometry. Under different experimental environments and storage conditions, this impurity remains stable and uniform. It can be used as a reliable reference substance for Trilaciclib impurity analysis, ensuring the accuracy and repeatability of detection results, and providing a solid guarantee for pharmaceutical quality research and quality control.
Application Fields:
Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Trilaciclib bulk drugs and formulations, ensuring that the sensitivity and specificity of the detection methods meet pharmaceutical quality standard requirements and effectively guaranteeing drug quality.
Process Optimization: During the production of Trilaciclib, by monitoring the content of this impurity and tracing its source, it helps to optimize the synthesis process, reduce impurity formation, and improve product quality.
Stability Studies: In drug stability tests, it analyzes the change trends of this impurity under different storage conditions (such as temperature, humidity, light), providing key data support for determining the shelf life and suitable storage conditions of drugs.
Background Description: Trilaciclib is an innovative drug used to protect bone marrow from chemotherapy damage and is of great significance in the field of cancer treatment. In the process of its research, development, production, and quality control, impurity research is a key link to ensure drug safety and effectiveness. The presence of impurities may affect the drug's efficacy and even pose potential risks. As a related impurity of Trilaciclib, in-depth research on Trilaciclib Impurity 4 helps to comprehensively and accurately evaluate the quality of Trilaciclib drugs, providing strong support for safe clinical medication.
Research Status: Currently, research on Trilaciclib Impurity 4 continues to deepen. In terms of detection technology, researchers are actively exploring advanced detection methods such as Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) and high-resolution mass spectrometry, aiming to achieve high-precision detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors of this impurity are deeply analyzed by simulating drug synthesis routes and storage environments, providing a theoretical basis for controlling impurities from the source. In addition, research on the impact of this impurity on the efficacy and safety of Trilaciclib is also gradually being carried out, with the aim of further improving the comprehensive understanding of the quality of Trilaciclib drugs
NOTE！
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!
China